These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
511 related items for PubMed ID: 20557313
21. Antiplatelet effect of aspirin in patients with coronary artery disease. Grove EL. Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204 [Abstract] [Full Text] [Related]
25. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease. Pamukcu B, Oflaz H, Onur I, Oncul A, Umman B, Koylan N, Bugra Z, Meric M, Nisanci Y. Blood Coagul Fibrinolysis; 2007 Jul 01; 18(5):461-5. PubMed ID: 17581321 [Abstract] [Full Text] [Related]
27. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. Angiolillo DJ, Bernardo E, Sabaté M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolin R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernandez-Ortiz A. J Am Coll Cardiol; 2007 Oct 16; 50(16):1541-7. PubMed ID: 17936152 [Abstract] [Full Text] [Related]
29. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Carvajal J, Lehmann A, Lambert M, Bonnet JL, Alessi MC. J Am Coll Cardiol; 2006 Oct 03; 48(7):1339-45. PubMed ID: 17010792 [Abstract] [Full Text] [Related]
30. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention. Buch AN, Singh S, Roy P, Javaid A, Smith KA, George CE, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R. Am J Cardiol; 2007 Jun 01; 99(11):1518-22. PubMed ID: 17531573 [Abstract] [Full Text] [Related]
31. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Harmsze AM, Hackeng CM, ten Berg JM. Heart; 2011 Jun 01; 97(12):983-90. PubMed ID: 21478385 [Abstract] [Full Text] [Related]
38. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function. Bevilacqua S, Alkodami AA, Volpi E, Cerillo AG, Berti S, Glauber M, Gianetti J. Ann Thorac Surg; 2009 Feb 01; 87(2):496-502. PubMed ID: 19161767 [Abstract] [Full Text] [Related]